On behalf of our scientific & international committee, we welcome all the veterinary researchers, veterinary surgeons, veterinary professors, academicians, young researchers, scientists & all the emerging pillars of the veterinary field for the “4th World Congress on Veterinary medicine & Animal care” on December 09-10, 2022 in Dubai, UAE for the study of animal health and veterinary medicine.
Veterinary medicine 2022 promises to be a long-lasting event that will bring together speakers and delegates from all around the world.
Over 500 people are expected to attend, including international luminaries at the forefront of the field who will present the latest cutting-edge developments in fundamental veterinary medicine research.
We've planned scientific presentations around a variety of current and cutting-edge topics, as well as seminars and networking opportunities to encourage interaction.
This is an opportunity to participate in one of the most important international veterinary medicine conferences, held in one of the world's leading scientific superpowers.
Veterinary medicine 2022 can serve as a vital networking and intellectual gateway for industry, universities, healthcare suppliers, and independent research organizations.
The event is open to young investigators, physicians, scientists, researchers, trade partners, and policy activists.
Looking forward to seeing you in December 2022.
MIBA FZ LLC, Dubai
Founded in 2015, in close cooperation with MIBA Foundation (Netherlands), MIBA FZ LLC (UAE) is pioneering in the promising field of applied biophoton sciences.
Applications of the ultra-weak photon emissions of biological systems have shown great promise in optimizing physiological processes and regenerative capacity in both humans and animals, and as such can be considered a useful addition in preventive and curative (veterinary) care.
The optical EluxR® technology that MIBA’s founder Dr. J.C. Boswinkel has developed, tested, and applied over a period of 39 years is designed to increase biophoton coherence, resulting in improved immune functions and thereby less need for other interventions.
Since the 1980s, Dr. Boswinkel has developed a thorough understanding of biophotons and their effect on human health by working successfully with over 25,000 clients worldwide. The therapeutic methodology that resulted from his findings has the ultimate goal to, in his own words: “Restore the capacity for self-healing, reignite respect for nature's intelligence and reduce dependency on medication or invasive procedures whenever possible.”
In the early 2000s, a training arm of the foundation was set up to share Dr. Boswinkel’s expertise. Hundreds of therapists worldwide now use his optical therapy instruments (EluxR® technology) successfully, many of whom are former clients who experienced miraculous turnarounds in their own health.
Apart from clinical applications of this optical technology, several research studies that were conducted at Dr. Fritz-Albert Popp’s International Institute of Biophysics (Neuss, Germany), and more recently at the Inter-University College Graz (Graz, Austria) as part of its EU-sponsored program in cooperation with the Institute of Applied Biophoton Sciences (Drammen, Norway), have shown relevance of biophoton coherence for the fields of agriculture, pest control and the food industry.
To date, 17 master’s theses have demonstrated the effectiveness of Dr. J.C. Boswinkel’s biophoton technology. We are just beginning to explore the full range of possibilities that can be realized.
Although Dr. Boswinkel’s therapy devices were initially designed for human treatment, therapists reported successfully using certain therapeutic procedures on their domestic animals as well. And after our market research in 2017-2018 revealed much interest in the UAE for the specific use of the EluxR® technology for veterinary care, MIBA FZ decided to fully customize the therapy device to this purpose.
In 2019, the EluxR® instrument and training module for veterinary treatment became first available. Currently, this device is used in the equine sports and breeding industries, but the therapy can be effectively and safely applied to other animal species as well (e.g., pets, cattle and zoo animals).
Due to the positive effects on health, performance, as well as wellbeing of animals, the therapy has a broad scope of application and may be useful in many animal-based industries. The safety and ease of use of the EluxR® device make it accessible to both veterinarians and non-professional animal caretakers. Our target markets are: (sports/performance) animal owners; the animal breeding industry; the wildlife conservation industry; the livestock industry; and veterinary clinics.
Fujifilm Medical Systems, Dubai
Think “Fujifilm” and the words camera or photography will likely come to mind, the consequence of many decades of imaging excellence.
But we are more than imaging alone. Indeed, we have been making important contributions to healthcare since 1936 with the launch of our first X-ray business.
Today, our holistic medical solutions are helping to revolutionize diagnostics and support physicians in providing quality and critical care. Through using Fujifilm AI technology, for example, surgeons may now detect retained gauze or foreign objects in post-surgery X-ray images.
Spanning categories including Invitro Diagnostics, Point of Care Ultrasound, Radiology and Healthcare IT, our expanded portfolio of healthcare solutions was presented by product specialists directly, marking a departure from previous years – including the following below.
Invitro Diagnostics-Veterinary Diagnostics Products
Fujifilm Dry Chemistry Units
Fujifilm’s dry chemistry units are small instruments with advanced features and can analyze up to 31 parameters with options of 120 tests/hour or 190 tests/hour. Critical importance tests for animals can be rapidly tested and can play vital role in the diagnosis in the animals.
Other important parameters such as such as Cortisol, Bile Acids, Pregesterone,T4, and TSH tests can be performed rapidly and accurately with our cutting edge technology of AU10V which is an auto immuno analyzer.
Register your company to join as Exhibitor at Veterinary Medicine 2022:
Abstract submission: November 15, 2022
First phase registration: August 15, 2022
Second phase registration: November 10, 2022
Final registration: November 27, 2022
Book your slot: https://veterinarymedicine.pulsusconference.com/registration
Group registration(Minimum 5 members) can avail 15% waivers from the registration fee.
Email Jessica Lois at firstname.lastname@example.org or whatsapp +442080400181 with details of the 5 participants.
- Anaesthesia, Analgesia & Pain management
- Animal welfare & Behavioral medicine
- Clinical pharmacology
- Emergency and Critical care
- Internal medicine
- Laboratory animal medicine
- Nutrition & Meat science
- Poultry & Dairy practice
- Preventive medicine
- Surgery & Radiology
- Avian practice
- Beef cattle practice
- Canine and Feline practice
- Equine practice
- Exotic companion mammal practice
- Animal vaccines
- Camel Science
- Zoological medicine
- Reptile and Amphibian practice
- Swine health management
- Sports medicine and rehabilitation
- Bee Health
The estimated size of the worldwide veterinary medication market in 2021 was USD 29.4 billion, and from 2022 to 2030, it is anticipated to expand at a compound annual growth rate (CAGR) of 7.3%. The increase in zoonotic and chronic sickness incidence is the main factor driving this market. Over the past few decades, the world's livestock population has likewise been expanding quickly. In July 2020, there were around 103 million cattle and 32.05 million beef cows in the United States, according to the USDA, and this number is anticipated to increase significantly over the next few years. Additionally, rising R&D and procedural developments, the rate of pet adoption, rising meat consumption, and mandated vaccination are all predicted to increase the need for veterinary medications and animal vaccines in the near future.